衰老心脏:体循环与冠状动脉循环
多数心血管病发生于60岁以上人群,但随机试验中老年人代表性不足,指南证据有限。血压随增龄因动脉僵硬度增加而升高,更严格控制改善结局;心肌缺血随年龄更常见,老年患者不良结局更多却较少接受指南治疗。衰弱是60岁以上成人死亡的独立预测因素但评估不足,非衰弱老年患者可从治疗显著获益,亟需将衰弱纳入临床试验。
要点
- 老年人随机试验代表性不足,指南证据有限。
- 血压随增龄因动脉僵硬度增加而升高,更严格控制改善结局。
- 衰弱是60岁以上成人死亡的独立预测因素,非衰弱老年患者可从治疗显著获益。
核心结论
- 多数心血管病发生于60岁以上人群,但当前指南因随机试验中老年人代表性不足而缺乏老年人群证据。
- 衰弱是60岁以上成人死亡的独立预测因素,但评估仍不充分,亟需将衰弱纳入心血管病治疗临床试验。
研究设计与样本
- 综述,评估关于衰老过程中心血管变化的文献,聚焦体循环与冠状动脉循环,特别强调衰弱及其在心血管病评估和治疗中的意义。
主要发现
- 血压随年龄增长因动脉僵硬度增加而升高,更严格的控制可改善结局。
- 心肌缺血随年龄增长更常见,由冠状动脉疾病和心肌改变共同导致。
- 老年患者不良结局发生率更高,但接受指南为基础治疗的比例更低。
- 衰弱是60岁以上成人死亡的独立预测因素,但评估仍不充分。
- 步速缓慢是衰弱发生和干预后不良结局的关键标志。
关键数值与推荐
- 血压随年龄增长因动脉僵硬度增加而升高,更严格的控制可改善结局。
- 衰弱是60岁以上成人死亡的独立预测因素。
- 步速缓慢是衰弱发生和干预后不良结局的关键标志。
- 非衰弱老年患者可从治疗中获得显著获益。
临床怎么用
- 老年心血管病患者应评估衰弱状态,步速缓慢可作为关键标志。
- 非衰弱老年患者可从指南为基础的治疗中显著获益。
- 老年患者不应仅因年龄而较少接受指南为基础的治疗。
局限性
- 随机试验中老年人代表性不足,导致当前指南缺乏老年人群证据。
- 衰弱评估仍不充分,且少有试验在年龄之外独立评估衰弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most cardiovascular disease (CVD) occurs in patients over the age of 60. However, most evidence-based current cardiovascular guidelines lack evidence in an older population, due to the under-representation of older patients in randomised trials. Blood pressure rises with age due to increasing arterial stiffness, and stricter control results in improved outcomes. Myocardial ischaemia is also more common with increasing age, due to a combination of coronary artery disease and myocardial changes. However, despite higher rates of adverse outcomes, older patients are offered guideline-based therapy less frequently. Frailty is an independent predictor of mortality in adults over the age of 60, yet remains poorly assessed; slow gait speed is a key marker for the development of frailty and for adverse outcomes following intervention. Few trials have assessed frailty independent of age; however, there is evidence that non-frail older patients derive significant benefit from therapy, highlighting the urgent need to include frailty as a measure in clinical trials of treatment in CVD.In this review, the authors appraise the literature in regard to the cardiovascular changes with ageing, specifically in relation to the systemic and coronary circulation and with a particular emphasis on frailty and its implication in the evaluation and treatment of CVD.
引用
- Nanayakkara S, Marwick TH, Kaye DM, et al. The ageing heart: the systemic and coronary circulation. Heart. 2017. PMID: 29092917. doi:10.1136/heartjnl-2017-312114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。